For richer charts and full features, open SpikePanel on desktop.

Biotech catalyst calendar

Track clinical readouts, regulatory milestones and market repricing by date.

Updated 10/28, 01:01 PM · US Eastern time · Selected public disclosures. This calendar is not exhaustive.

FDA official calendar

October 2026

Linked stocks only

24 events · 24 stocks

MonTueWedThuFriSatSun

Wed, October 28

0 events

No collected events on this day.

Prices and changes reflect the labeled regular, pre-market, after-hours or closed session, not the event day. First close is the change from the baseline to the first post-disclosure close, shown only with verified timing and history.

Upcoming catalysts

PDUFA dates are review targets. They do not guarantee approval or a decision on that day. Selected public disclosures. This calendar is not exhaustive.

Updated 10/28, 01:01 PM · US Eastern time

UpcomingPDUFA targetIn 2 days

INO-3107

Indication not verified; see the original disclosure.

Review target / meeting date

Oct 30, 2026

Evidence source

Company disclosure

$INO

Quote unavailable

Price trend

Loading price history…

Company & funding

Market cap snapshot: $54.9M; 10/21
Cash & short-term investments: $36.7M
Total debt: $8M
Quarterly operating cash burn: $18M

Statement period end: 2026-06-30 · FMP financial data. Filed: 2026-08-12.

About 6.1 months from period end · estimated through 2027-01-01

Cash plus short-term investments divided by that quarter’s operating burn, anchored to the statement date, not today. Excludes later financing, capex, debt repayment and development expansion; not an assurance of funding.

SEC filings

Drug and event discussions

Matches drug names with clinical or regulatory terms in collected posts. Generic ticker mentions and other events are kept separate.

Xreactions

Last 14 days

1 matching posts/comments · 1 authors

@bussinbiotech
…;15% today on big volume despite the favorable litigation news from yesterday? Someone knows that a INO-3107 CRL is coming? $PGEN
10/2111

Search related discussions on X

Keyword matches in up to 200 monitored items per ticker and platform. Not a full-platform sentiment measure or evidence of a clinical or regulatory outcome. Updated 10/28, 01:01 PM ET · Refreshed hourly.

Other stock discussions · not linked to this event

Xreactions

Last 14 days

2 collected posts/comments · 2 authors

Search related discussions on X

Recent discussions of this stock, not necessarily this FDA event. Original excerpts; monitored coverage only, not a full-platform sentiment poll. Updated 10/28, 01:01 PM ET · Refreshed hourly.

Disclosure & review details

Review outcome

Waiting for an explicit outcome disclosure. A PDUFA date is a review target, not a guaranteed approval date.

Evidence & updates

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

… for Recurrent Respiratory Papillomatosis (RRP) advancing with a target Prescription Drug User Fee Act (PDUFA) date of October 30, 2026 Commercial preparations advancing in anticipation of potential product launch for …